85 related articles for article (PubMed ID: 6002976)
1. [Snake venoms as a source of anticancerous enzymes. I. Fundamental biochemical aspects of the problem].
Gillo L
Mem Inst Butantan; 1966; 33(3):933-6. PubMed ID: 6002976
[No Abstract] [Full Text] [Related]
2. [Snake venoms, as a source of anticancerous enzymes. II. Experimental study].
Wirtheimer C; Gillo L
Mem Inst Butantan; 1966; 33(3):937-42. PubMed ID: 6002977
[No Abstract] [Full Text] [Related]
3. [Toxicology of snake venom].
Policlinico Prat; 1971 Sep; 78(18):758-62. PubMed ID: 5165403
[No Abstract] [Full Text] [Related]
4. Enzymes of snake venoms as tools in biochemical research.
Zeller EA
Mem Inst Butantan; 1966; 33(2):349-57. PubMed ID: 6012213
[No Abstract] [Full Text] [Related]
5. [Therapeutic defibrination using snake venom (Arvin) in arterial circulation disorders].
Ehringer H; Dudczak E; Lechner K; Widhalm F
Verh Dtsch Ges Inn Med; 1972; 78():624-7. PubMed ID: 4677225
[No Abstract] [Full Text] [Related]
6. 5'-Nucleotidase activity in snake venoms.
Devi A; Ashgar SS; Sarkar NK
Mem Inst Butantan; 1966; 33(3):943-9. PubMed ID: 6002978
[No Abstract] [Full Text] [Related]
7. Cardiovascular responses to snake venoms and their fractions.
Russell FE
Mem Inst Butantan; 1966; 33(2):583-8. PubMed ID: 6002429
[No Abstract] [Full Text] [Related]
8. Serotonin and related tryptamine derivatives in snake venoms.
Welsh JH
Mem Inst Butantan; 1966; 33(2):509-18. PubMed ID: 6002423
[No Abstract] [Full Text] [Related]
9. Separation methods of animal venoms constittents.
Suzuki T
Mem Inst Butantan; 1966; 33(2):389-409. PubMed ID: 4882906
[No Abstract] [Full Text] [Related]
10. Specific sites of action of snake venoms in the central nervous system.
Bicher HI
Mem Inst Butantan; 1966; 33(2):523-39. PubMed ID: 6002425
[No Abstract] [Full Text] [Related]
11. Isolation from cobra venom of a factor inhibiting glycolysis in Ehrlich ascites carcinoma cells.
Brisbois L; Rabinovitch-Mahler N; Gillo L
Experientia; 1968 Jul; 24(7):673-4. PubMed ID: 5705221
[No Abstract] [Full Text] [Related]
12. Biological and viscosimetric measurement of hyaluronidase content of some Egyptian snake venoms.
Mohamed AH; el-Karimi MM
J Trop Med Hyg; 1969 Mar; 72(3):79-80. PubMed ID: 5813268
[No Abstract] [Full Text] [Related]
13. Pharmacologically and biochemically active components of Japanese ophidian venoms.
Suzuki T
Mem Inst Butantan; 1966; 33(2):519-21. PubMed ID: 6002424
[No Abstract] [Full Text] [Related]
14. Some separation methods based on molecular size and charge and their application to purification of polypeptides and proteins in snake venoms.
Porath J
Mem Inst Butantan; 1966; 33(2):379-87. PubMed ID: 4882905
[No Abstract] [Full Text] [Related]
15. Snake venom fibrin(ogen)olytic enzymes.
Swenson S; Markland FS
Toxicon; 2005 Jun; 45(8):1021-39. PubMed ID: 15882884
[TBL] [Abstract][Full Text] [Related]
16. Cross reactivity between venomous, mildly venomous, and non-venomous snake venoms with the Commonwealth Serum Laboratories Venom Detection Kit.
Jelinek GA; Tweed C; Lynch D; Celenza T; Bush B; Michalopoulos N
Emerg Med Australas; 2004; 16(5-6):459-64. PubMed ID: 15537410
[TBL] [Abstract][Full Text] [Related]
17. Neurotoxic effects of venoms from seven species of Australasian black snakes (Pseudechis): efficacy of black and tiger snake antivenoms.
Ramasamy S; Fry BG; Hodgson WC
Clin Exp Pharmacol Physiol; 2005; 32(1-2):7-12. PubMed ID: 15730427
[TBL] [Abstract][Full Text] [Related]
18. Extremely low nerve growth facior (NGF) activity of sea snake (Hydrophiidae) venoms.
Mariam K; Tu AT
J Nat Toxins; 2002 Dec; 11(4):393-8. PubMed ID: 12503884
[TBL] [Abstract][Full Text] [Related]
19. [Improvement of blood viscosity through Arvin].
Ehrly AM; Breddin K
Verh Dtsch Ges Inn Med; 1972; 78():620-4. PubMed ID: 4677224
[No Abstract] [Full Text] [Related]
20. [Immunoelectrophoretic analysis applied to snake venoms].
Jouannet M
Toxicon; 1968 Feb; 5(3):191-9. PubMed ID: 5640302
[No Abstract] [Full Text] [Related]
[Next] [New Search]
